November Newsmakers

Understanding the Side Effects from Immunotherapy for Lung Cancer (U.S. News & World Report)
Features Jennifer Garst, MD

WATCH: ASCO 2017: Options for NSCLC Patients Progressing After EGFR Treatment (Journal of Thoracic Oncology)
Features Thomas Stinchcombe, MD

Using Photography to Track Progress of Head and Neck Cancers (ONS Voice)
Features John Hillson, RN, OCN, Radiation Oncology, Duke Cancer Center 

Duke Scientists Explore Cancer Link to Flame-Retardants (NC Health News)
Features Julie Ann Sosa, MD, MS

Joan Tisch, billionaire matriarch and philanthropist, dies at 90 (The Washington Post)
Features The Preston Robert Tisch Brain Tumor Center

Reaching Out: Cancer Program-Community Collaborations for Health Equity (ACCC Buzz)
Features Nadine Barrett, PhD 

WATCH: Building Community Partnerships To Improve Cancer Outcomes (Cure Today)
Features Nadine Barrett, PhD 

WATCH: Presentations from the 2017 Living With Melanoma Symposium at Duke Cancer Institute (AIM at Melanoma)

WATCH: Dr. Neil Spector’s “Focus on Lyme” (
Features Neil Spector, MD

Cabozantinib RCC Benefit Highlighted as Frontline Approval Approaches (OncLive)
Features Michael Harrison, MD

Singapore Partnership Offers Valuable Insight (Duke Surgery)
Features Allan Kirk, MD, PhD

Dr. Berry on LHRH Antagonists Versus Agonists for Prostate Cancer (OncLive
Features William R. Berry, MD 

Get a Plan to Quit During Great American Smokeout (Duke Today)
Features tobacco cessation programs at Duke

COUNTERPOINT—Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? (Cancer Network/Oncology Journal)
Features Judd Moul, MD

Substance in Birthwort Plant, Staple of Herbal Medicine, Linked to Liver Cancer (The Wire)
Features Steve Rozen, PhD, Duke-NUS

Duke University Models How and Where Blood Flow Impacts Health (R&D Magazine)
Features Amanda Randles, PhD

VEGF inhibitors may augment immunotherapy efficacy for first-line renal cell carcinoma (HemOnc Today)
Features Tian Zhang, MD


Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All? Journal of Clinical OncologyAndrew Berchuck, MD; Angeles Alvarez Secord, MD; Haley A. Moss, MD, MBA; Laura J. Havrilesky, MD, MHSc.  

How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer (featured in Best of JCO 2017 Head and Neck Cancer Edition) Timothy J. Robinson, MD, PhD; Samantha Thomas, MS; Michaela A. Dinan, PhD; Sanziana Roman, MD, FACS; Julie Ann Sosa, MD, MS; Terry Hyslop, PhD  

Epidermal Growth Factor and Granulocyte Colony Stimulating Factor Signaling Are Synergistic for Hematopoietic RegenerationStem CellsPiryani, SOKam, AYFKliassov, EGChen,  BJSpector, NL; Chute, JP; Hsu, DSChao, NJDoan, PL

Prostate cancer–associated SPOPmutations confer resistance to BET inhibitors through stabilization of BRD4 Nature. Xiangpeng Dai; Wenjian Gan; Xiaoning Li; Shangqian Wang; Wei Zhang; Ling Huang; Shengwu Liu; Qing Zhong; Jianping Guo; Jinfang Zhang; Ting Chen; Kouhei Shimizu; Francisco Beca; Mirjam Blattner; Divya Vasudevan; Dennis L Buckley; Jun Qi; Lorenz Buser; Pengda Liu; Hiroyuki Inuzuka; Andrew H Beck; Liewei Wang; Peter J Wild; Levi A Garraway; Mark A Rubin; Christopher E Barbieri; Kwok-Kin Wong; Senthil K Muthuswamy; Jiaoti Huang; Yu Chen; James E Bradner; Wenyi Wei